Nurşen Belet

Prof. Nurşen Belet


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2013 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
AKArzu Karli
Arzu Karli
MPMuhammet Sukru Paksu
Muhammet Sukru Paksu
AKAdil Karadag
Adil Karadag
NBNurşen Belet
Nurşen Belet
SPSule Paksu
Sule Paksu
SSSema Gulnar Sensoy
Sema Gulnar Sensoy
The aim of this study was to investigate the efficacy and safety of colistin therapy in pediatric patients with severe nosocomial infections in pediatric intensive care unit.

1 January 2006 in Scandinavian Journal of Infectious Diseases
Verified
Journal Article
Closed access
NBNurşen Belet
Nurşen Belet
EÇErgin Çiftçi
Ergin Çiftçi
EIErdal Ince
Erdal Ince
NDNazan Dalgiç
Nazan Dalgiç
Selim ÖNCELSelim ÖNCEL
Selim ÖNCEL
ÜDÜlker Doğru
Ülker Doğru
Candida lipolytica has infrequently been identified as a cause of infection and is associated mostly with vascular catheter-related fungaemia. Patients reported in the literature have been successfully treated with catheter removal or amphotericin B treatment. We report 2 infants with C. lipolytica fungaemia unresponsive to catheter removal and amphotericin B therapy and treated successfully with the addition of caspofungin to amphotericin B.

1 February 2002 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
NBNurşen Belet
Nurşen Belet
ÜBÜmit Belet
Ümit Belet
ATAtilla Tekat
Atilla Tekat
ŞKŞükrü Küçüködük
Şükrü Küçüködük

1 August 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
NBNurşen Belet
Nurşen Belet
ATAyşe Top
Ayşe Top
ÖTÖzlem Terzi
Özlem Terzi
HAHatice Nilden Arslan
Hatice Nilden Arslan
KBKemal Baysal
Kemal Baysal
GŞGülnar Şensoy
Gülnar Şensoy
Background: Crimean-Congo hemorrhagic fever (CCHF) is endemic in some regions of our country. It is seen in all age groups; however, its prevalance is low in children. The studies on CCHF have been mostly in adults. The aim of this study was to evaluate the epidemiologic, demographic, clinical and laboratory findings of children with CCHF. Methods: Between May 2008 and September 2011, the medical records of patients who were admitted to the Children Infectious Diseases Service of Ondokuz Mayis University School of Medicine with positive blood IgM by enzyme-linked immunosorbent assay or polymerase chain reaction positive for CCHF were retrospectively evaluated. Epidemiologic and demographic features, clinical and laboratory data and therapy were recorded. Results: Fifty-four patients with the diagnosis of CCHF were recorded between May 2008 and September 2011. Main symptoms during hospital admission were fever (98%), vomiting (59%), headache (39%), nausea (39%), diarrhea (22%), abdominal pain (22%), bleeding (22%) and rash (20%). During admission, thrombocytopenia was found in 74%, elevated aspartate aminotransferase in 61%, leucopenia in 57%, elevated creatine kinase (33%) and alanine aminotransaminase (29%), and prolonged prothrombin time and partial thromboplastine time in 28% were noted. Thirty-nine patients received ribavirin treatment. During clinical follow up, bradycardia was recorded in 18 patients (33%) all of whom received ribavirin treatment. One patient died. Conclusions: This study reports the largest series of children with CCHF and the first to describe bradycardia associated with ribavirin therapy.

1 September 2023 in Turkish Journal of Hematology
Verified
Journal Article
Open access
IEIrem Ceren Erbaş
Irem Ceren Erbaş
AGAyşe Çakıl Güzin
Ayşe Çakıl Güzin
SASilem OZDEM ALATAŞ
Silem OZDEM ALATAŞ
HAHatice Karaoğlu Asrak
Hatice Karaoğlu Asrak
İAİLKNUR AKANSU
İLKNUR AKANSU
NBNurşen Belet
Nurşen Belet
Febrile neutropenia (FN) is an important complication that causes high rates of morbidity and mortality in patients with malignancies. We aimed to investigate the etiology, epidemiological distribution and its change over the years, clinical courses, and outcomes of FN in children with acute leukemia. We retrospectively analyzed the demographic data, clinical characteristics, laboratory results, severe complications, and mortality rates of pediatric patients with FN between January 2010 and December 2020. In 153 patients, a total of 450 FN episodes (FNEs) occurred. Eighty-four (54.9%) of these patients were male, the median age of the patients was 6.5 (range: 3-12.2) years, and 127 patients (83%) were diagnosed with acute lymphoblastic leukemia. Fever with a focus was found in approximately half of the patients, and an etiology was identified for 38.7% of the patients. The most common fever focus was bloodstream infection (n=74, 16.5%). Etiologically, a bacterial infection was identified in 22.7% (n=102), a viral infection in 13.3% (n=60), and a fungal infection in 5.8% (n=26) of the episodes. Twenty-six (23.2%) of a total of 112 bacteria were multidrug resistant (MDR) The rate of severe complications was 7.8% (n=35) and the mortality rate was 2% (n=9). In logistic regression analysis, refractory/relapsed malignancies and high C-reactive protein (CRP) at first admission were found to be the most important independent risk factors for mortality. Prolonged neutropenia after chemotherapy, diagnosis of acute myeloid leukemia, identification of fever focus or etiological agents, invasive fungal infections, polymicrobial infections, and need for intravenous immunoglobulin treatment increased the frequency of severe complications. We found that there was no significant change in the epidemiological distribution or frequency of resistant bacteria in our center in the last 10 years compared to previous years. Prolonged duration of fever, relapsed/refractory malignancies, presence of fever focus, and high CRP level were significant risk factors for poor clinical course and outcome.

22 January 2024 in Children
Verified
Journal Article
Open access
PDF file
MNMerve Iseri Nepesov
Merve Iseri Nepesov
ÖKÖmer Kılıç
Ömer Kılıç
ESEnes Sali
Enes Sali
EYEdanur Yesil
Edanur Yesil
AAAsuman Akar
Asuman Akar
Ener Cagri DinleyiciEner Cagri Dinleyici
Ener Cagri Dinleyici
Objectives: Septic arthritis (SA) is a serious bacterial infection that must be treated efficiently and timely. The large number of culture-negative cases makes local epidemiological data important. Accordingly, this study aimed to evaluate the etiology, clinical characteristics, and therapeutic approach of SA in children in Turkiye, emphasizing the role of real-time polymerase chain reaction (PCR) techniques in the diagnosis. Methods: In this multi-center, prospective study, children hospitalized due to SA between February 2018 and July 2020 in 23 hospitals in 14 cities in Turkiye were included. Clinical, demographic, laboratory, and radiological findings were assessed, and real-time PCR was performed using synovial fluid samples. Results: Seventy-five children aged between 3 and 204 months diagnosed with acute SA were enrolled. Joint pain was the main complaint at admission, and the most commonly involved joints were the knees in 58 patients (77.4%). The combination of synovial fluid culture and real-time PCR detected causative bacteria in 33 patients (44%). In 14 (18.7%) patients, the etiological agent was demonstrated using only PCR. The most commonly isolated etiologic agent was Staphylococcus aureus, which was detected in 22 (29.3%) patients, while Streptococcus pyogenes was found in 4 (5.3%) patients and Kingella kingae in 3 (4%) patients. Streptococcus pyogenes and Kingella kingae were detected using only PCR. Most patients (81.3%) received combination therapy with multiple agents, and the most commonly used combination was glycopeptides plus third-generation cephalosporin. Conclusions: Staphylococcus aureus is the main pathogen in pediatric SA, and with the use of advanced diagnostic approaches, such as real-time PCR, the chance of diagnosis increases, especially in cases due to Kingella kingae and Streptococcus pyogenes.